ACARBZONE M 500 is a combination anti-diabetic medication that contains two active ingredients: Acarbose and Metformin Hydrochloride. This powerful combination is prescribed for the management of type 2 diabetes mellitus, especially in patients who are unable to control their blood sugar levels with diet and exercise alone. Developed with the expertise of Steris Healthcare, ACARBZONE M 500 offers a dual mechanism of action to help patients achieve better glycemic control, reduce postprandial (after-meal) glucose spikes, and minimize long-term complications of diabetes. What is ACARBZONE M 500? ACARBZONE M 500 is an oral anti-diabetic tablet that combines two well-known glucose-lowering agents: Acarbose: An alpha-glucosidase inhibitor that works by slowing down the digestion and absorption of carbohydrates in the intestine, thereby preventing sudden spikes in blood sugar after meals. Metformin: A biguanide class drug that decreases glucose production in the liver and improves insulin sensitivity in the body, thereby helping cells use glucose more effectively. Together, these ingredients offer comprehensive glucose control by targeting different pathways in the body. Uses of Acarbose and Metformin Tablet: Treatment of type 2 diabetes mellitus in adults Helps manage postprandial hyperglycemia (blood sugar rise after eating) Improves glycemic control when lifestyle modifications (diet and exercise) are insufficient Reduces the risk of long-term diabetic complications such as neuropathy, nephropathy, and retinopathy Side Effects of Acarbose and Metformin Tablet: While ACARBZONE M 500 is generally well tolerated, some patients may experience: Gastrointestinal discomfort such as bloating, flatulence, diarrhea, or stomach pain (commonly due to acarbose) Nausea, metallic taste, or appetite loss (often associated with metformin) Vitamin B12 deficiency with long-term use of metformin Lactic acidosis (a rare but serious side effect of metformin; symptoms include fatigue, muscle pain, breathing difficulty, and dizziness) Mild skin rash or allergic reactions in sensitive individuals Precautions Before Using ACARBZONE M 500: Not recommended for patients with type 1 diabetes Avoid if you have a history of liver or kidney disease, gastrointestinal disorders, or chronic alcohol use Use cautiously in elderly patients and during pregnancy or breastfeeding (only under medical supervision) Regular monitoring of kidney function, blood glucose levels, and vitamin B12 is advised during prolonged use Drug Interactions – What Drugs Interact with Acarbose and Metformin? Several medications may interact with ACARBZONE M 500, potentially affecting its effectiveness or increasing the risk of side effects: Diuretics (e.g., furosemide), corticosteroids, or oral contraceptives may reduce its glucose-lowering effect Insulin or sulfonylureas can increase the risk of hypoglycemia when used with this combination Cimetidine or ranitidine may increase metformin levels Antibiotics like rifampicin or digestive enzyme preparations may interfere with acarbose activity Alcohol consumption should be minimized due to the risk of lactic acidosis Conclusion: ACARBZONE M 500 is a clinically effective treatment for managing type 2 diabetes. Its dual-action formula tackles both hepatic glucose production and post-meal sugar spikes, offering balanced glycemic control. Always consult your healthcare provider before starting or stopping this medication to ensure safe and optimal outcomes in your diabetes management journey.
| Active Ingredient: | Acarbose (50mg), Metformin (500mg) |
| Brand Name: | ACARBZONE M 500 |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Package SIZE | 10*10 Tablets |
| Colour | Titanium Dioxide IP & Yellow Oxide Of Iron |
| Dosage | As Directed By The Physician |
| Storage | Store In A Cool & Dry Place |
| Country of origin | INDIA |